Xtl Biopharmaceuticals (XTLB) Cash from Investing Activities (2009 - 2024)

Xtl Biopharmaceuticals (XTLB) posted quarterly Cash from Investing Activities of -$237000.0 for Q4 2024, down 23800.0% on a QoQ basis from $1000.0 in Q2 2016.

Xtl Biopharmaceuticals (XTLB) Cash from Investing Activities (2009 - 2024) Analysis & Trends

Xtl Biopharmaceuticals (XTLB) has reported Cash from Investing Activities for 9 consecutive years, with -$237000.0 the latest figure, recorded in Q4 2024.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to -$237000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$237000.0 (changed N/A YoY) and the FY2025 annual result came in at $522000.0, up 161.85% from the prior year.
  • Cash from Investing Activities fell to -$237000.0 in Q4 2024 per XTLB's latest filing, from $1000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for XTLB reached as high as -$237000.0 in Q4 2024 and fell as low as -$237000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn - -
4 BeOne Medicines 470.64 Bn 465.84 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 122.91 Bn 115.67 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.77 Bn 62.77 Bn - -
8 Argenx Se 56.21 Bn 51.02 Bn 1.41 Bn -
9 Revolution Medicines 37.60 Bn 37.60 Bn - 172.62 Mn
10 Xtl Biopharmaceuticals 2.51 Bn 2.51 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -237,000.00
Dec 31, 2024 -237,000.00
Jun 30, 2016 1,000.00
Jun 30, 2016 1,000.00
Dec 31, 2015 -54,000.00
Dec 31, 2015 -54,000.00
Sep 30, 2015 -63,000.00
Sep 30, 2015 -63,000.00
Jun 30, 2015 -14,000.00
Jun 30, 2015 -14,000.00
Dec 31, 2014 516,000.00
Dec 31, 2014 516,000.00
Sep 30, 2014 116,000.00
Sep 30, 2014 116,000.00
Jun 30, 2014 538,000.00
Jun 30, 2014 538,000.00
Mar 31, 2014 279,000.00
Mar 31, 2014 279,000.00
Dec 31, 2013 -945,000.00
Dec 31, 2013 -945,000.00